Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation

2011623 citationsJournal Articlebronze Open Access

Authors

John R. Wingard · Medical College of Wisconsin

Navneet S. Majhail · Fred Hutch Cancer Center

Ruta Brazauskas · Medical College of Wisconsin

Zhiwei Wang · Florida College

Kathleen A. Sobocinski · Medical College of Wisconsin

David A. Jacobsohn · Cleveland Clinic

Mohamed L. Sorror

Abstract

The prospect for long-term survival is excellent for 2-year survivors of allogeneic HCT. However, life expectancy remains lower than expected. Performance of HCT earlier in the course of disease, control of GVHD, enhancement of immune reconstitution, less toxic regimens, and prevention and early treatment of late complications are needed.

Topics & Keywords

Hematopoietic Stem Cell Transplantation Acute Lymphoblastic Leukemia research Chronic Myeloid Leukemia Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 29, Issue 16, pp. 2230-2239

DOI: 10.1200/jco.2010.33.7212

Field-Weighted Citation Impact: 12.51